Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004–2006 - Wang, Y; Bhattaram, AV; Jadhav, PR (J Clin Pharmacol, 2008)
et al.